Autosomal recessive spastic paraplegia type 57

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:431329OMIM:615658G11.4
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Autosomal recessive spastic paraplegia type 57 (also called SPG57 or AR-SPG57) is a very rare inherited neurological condition that affects the nervous system, particularly the long nerve fibers that run from the brain down through the spinal cord to the legs. These nerve fibers, called corticospinal tracts, gradually lose their ability to work properly over time. This leads to progressive stiffness and weakness in the legs, a condition doctors call spastic paraplegia or spastic paraparesis. SPG57 is caused by changes (mutations) in a gene called TFG, which provides instructions for making a protein important for the health and function of nerve cells. When this protein does not work correctly, the long nerve fibers slowly break down. The condition typically begins in childhood or early adulthood, and the main symptoms include increasingly stiff and weak legs, difficulty walking, and problems with balance and coordination. Some people also develop additional neurological features such as reduced sensation in the limbs, vision problems related to the optic nerve, and in some cases mild intellectual difficulties. At this time, there is no cure for SPG57. Treatment focuses on managing symptoms, maintaining mobility, and improving quality of life. Physical therapy, occupational therapy, and medications to reduce muscle stiffness are the main tools available. With the right support, many people with SPG57 can maintain a good level of independence, especially in the earlier stages of the disease.

Also known as:

Key symptoms:

Progressive stiffness (spasticity) in the legsMuscle weakness in the legsDifficulty walking or an abnormal walking pattern (gait problems)Problems with balance and coordinationReduced sensation or numbness in the hands and feetMuscle wasting (loss of muscle bulk) in the limbsOveractive reflexes in the legsOptic nerve problems that can affect visionMild intellectual disability in some casesBladder control difficulties in some individualsFatigue related to the effort of walking

Clinical phenotype terms (14)— hover any for plain English
Abnormality of peripheral nerve conductionHP:0003134Difficulty standingHP:0003698Abnormal Achilles tendon morphologyHP:0005109Motor polyneuropathyHP:0007178Abnormal myelinationHP:0012447
Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Childhood

Begins in childhood, roughly ages 1 to 12

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Autosomal recessive spastic paraplegia type 57.

View clinical trials →

No actively recruiting trials found for Autosomal recessive spastic paraplegia type 57 at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Autosomal recessive spastic paraplegia type 57 community →

No specialists are currently listed for Autosomal recessive spastic paraplegia type 57.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Autosomal recessive spastic paraplegia type 57.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Autosomal recessive spastic paraplegia type 57Forum →

No community posts yet. Be the first to share your experience with Autosomal recessive spastic paraplegia type 57.

Start the conversation →

Latest news about Autosomal recessive spastic paraplegia type 57

No recent news articles for Autosomal recessive spastic paraplegia type 57.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.What genetic testing do you recommend to confirm the diagnosis, and should other family members be tested?,How quickly do you expect the symptoms to progress in my case, and what signs should I watch for?,What physical therapy program would you recommend, and how often should I attend?,Are there any clinical trials or research studies for SPG57 or related conditions that I might be eligible for?,What medications are available to help with leg stiffness, and what are the risks and benefits of each?,What mobility aids or home modifications should I consider now or plan for in the future?,Are there any patient registries or specialist centers for hereditary spastic paraplegia that you would recommend?

Common questions about Autosomal recessive spastic paraplegia type 57

What is Autosomal recessive spastic paraplegia type 57?

Autosomal recessive spastic paraplegia type 57 (also called SPG57 or AR-SPG57) is a very rare inherited neurological condition that affects the nervous system, particularly the long nerve fibers that run from the brain down through the spinal cord to the legs. These nerve fibers, called corticospinal tracts, gradually lose their ability to work properly over time. This leads to progressive stiffness and weakness in the legs, a condition doctors call spastic paraplegia or spastic paraparesis. SPG57 is caused by changes (mutations) in a gene called TFG, which provides instructions for making a

How is Autosomal recessive spastic paraplegia type 57 inherited?

Autosomal recessive spastic paraplegia type 57 follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Autosomal recessive spastic paraplegia type 57 typically begin?

Typical onset of Autosomal recessive spastic paraplegia type 57 is childhood. Age of onset can vary across affected individuals.